Comparative effect of calcium supplementation on the incidence of pre-eclampsia and eclampsia among primigravid women

Main Article Content

Assontsa Kafack Carole
Essiben Felix
Tumasang Florence
Meka Esther Juliette
Tongo Sedrick Fofack
Mbu Robinson Enow

Abstract

Background: Pre-eclampsia is a frequent and serious pregnancy complication contributing for the increasing maternal morbi-mortality rates. This study was designed to evaluate the effect of calcium supplementation during pregnancy, on the incidence of pre-eclampsia and eclampsia among primigravid women.


Method: In a hospital-based, opened, randomized and controlled clinical trial carried out in the city of Yaounde, 70 women were randomized to either 1.5 g daily calcium supplements (n = 35) or vitamins at the same time (n = 35) from 20 weeks gestation till delivery. Were included all singleton healthy, primigravid women who offered their signed inform consent and were excluded, all women with any chronic condition. Primary outcomes were pre-eclampsia and eclampsia.


Results: No significant difference was observed between the two study groups with respect to the baseline characteristics obtained at enrollment. We recorded a sevenfold decrease in the incidence of preeclampsia in the calcium group (RR = 0.26, CI 0.06 – 0.44, p = 0.024). The onset of pre-eclampsia was delayed 3 weeks in the calcium group. Meanwhile the mean diastolic blood pressure at delivery was of no significant difference (p = 0.126), the mean systolic blood pressure at delivery however, presented a significant difference between both groups (p = 0.009).


Conclusion: A 1.5 g daily calcium supplementation of healthy normotensive primigravid women during pregnancy seems to be effective in reducing the incidence of pre-eclampsia.

Article Details

Carole, A. K., Felix, E., Florence, T., Juliette, M. E., Fofack, T. S., & Enow, M. R. (2019). Comparative effect of calcium supplementation on the incidence of pre-eclampsia and eclampsia among primigravid women. Clinical Journal of Obstetrics and Gynecology, 2(2), 145–149. https://doi.org/10.29328/journal.cjog.1001038
Research Articles

Copyright (c) 2019 Carole AK, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Cunningham F, Kenneth J, Steven L, Jodi S, Barbara L, et al. Williams Obstetrics. 25th Edition. New York: The McGraw-Hill Companies; 706–748.

Gathiram P, Moodley J. Pre-eclampsia: its pathogenesis and pathophysiolgy. Cardiovasc J Afr. 2016; 27: 71–78. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27213853

Bartsch E, Medcalf KE, Park AL, Ray JG. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016; i1753. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27094586

Yigzaw M, Zakus D, Tadesse Y, Desalegn M, Fantahun M. Paving the way for universal family planning coverage in Ethiopia: an analysis of wealth related inequality. Int J Equity Health. 2015; 14: 77. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26369946

Ahmad A, Samuelsen S. Hypertensive disorders in pregnancy and fetal death at different gestational lengths: a population study of 2 121 371 pregnancies: Hypertensive disorder in pregnancy and fetal death. BJOG Int J Obstet Gynaecol. 2012; 119: 1521–1528. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22925135

Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014; 2: e323–333.

Kenny LC, Black MA, Poston L, Taylor R, Myers JE, et al. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for Pregnancy Endpoints (SCOPE) international cohort study. Hypertension. 2014; 64: 644–652. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25122928

World Health Organization, UNICEF, United Nations, Department of Economic and Social Affairs, Population Division, World Bank. Trends in maternal mortality: 1990 to 2015 : estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division [Internet]. 2015 [cited 2018 Dec 14]. http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-2015/en/

Hodgins S. Pre-eclampsia as Underlying Cause for Perinatal Deaths: Time for Action. Glob Health Sci Pract. 2015; 3: 525–527. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682577/

Mboudou ET, Foumane P, Priso EB, Dohbit J, Minkande JZ, et al. Hypertension in pregnancy: Clinical and epidemiologic aspects at the Yaounde Gyneco-obstetric and Pediatric Hospitalau cours de la grossesse, Cameroon. Clin Mother Child Health. 2009; 6: 1087–1093.

Tebeu PM, Halle-Ekane G, Da Itambi M, Mbu RE, Mawamba Y, et al. Maternal mortality in Cameroon: a university teaching hospital report. Pan Afr Med J. 2015; 21: 16. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561158/

World Health Organization. Cooperation strategy: Health situation in Cameroon [Internet]. 2015. http://apps.who.int/gho/data/node.cco

Jim B, Karumanchi SA. Preeclampsia: Pathogenesis, Prevention, and Long-Term Complications. Semin Nephrol. 2017; 37: 386–397. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28711078

Aghamohammadi A, Zafari M. Calcium supplementation in pregnancy and prevention of hypertensive disorders in elderly women. Science Asia. 2015; 41: 259.

Kumar A, Devi SG, Batra S, Singh C, Shukla DK. Calcium supplementation for the prevention of pre-eclampsia. Int J Gynaecol Obstet. 2009; 104: 32–36. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18851852

Chen Q, Tong M, Wu M, Stone PR, Snowise S, et al. Calcium supplementation prevents endothelial cell activation: possible relevance to preeclampsia. J Hypertens. 2013; 31: 1828-1836. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23822977

Samimi M, Kashi M, Foroozanfard F, Karamali M, Bahmani F, et al. The effects of vitamin D plus calcium supplementation on metabolic profiles, biomarkers of inflammation, oxidative stress and pregnancy outcomes in pregnant women at risk for pre-eclampsia. J Hum Nutr Diet. 2016; 29: 505–515. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26467311

Shin CS, Kim KM. The Risks and Benefits of Calcium Supplementation. Endocrinol Metab. 2015; 30: 27-34. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384676/

Taherian AA, Taherian A, Shirvani A. Prevention of preeclampsia with low-dose aspirin or calcium supplementation. Arch Iranian Med 2002; 5: 151–156.

Imdad A, Bhutta ZA. Effects of Calcium Supplementation during Pregnancy on Maternal, Fetal and Birth Outcomes: Calcium supplementation during pregnancy. Paediatr Perinat Epidemiol. 2012; 26: 138–152. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22742607

Arthur TE, Sonya S, Ryan S, Rosanne H. Manual of Obstetrics. 7th Edition. Lippincott Williams and Wikins; 2007. 178–185.

Herrera J, Arevaloherrera M, Shahabuddin A, Ersheng G, Herrera S, et al. Calcium and Conjugated Linoleic Acid Reduces Pregnancy-Induced Hypertension and Decreases Intracellular Calcium in Lymphocytes. Am J Hypertens. 2006; 19: 381–387. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16580574